Kerry A. Wentworth
2011
In 2011, Kerry A. Wentworth earned a total compensation of $680K as Vice President, Clinical, Regulatory and Quality at Agenus, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $62,104 |
|---|---|
| Option Awards | $265,867 |
| Salary | $254,400 |
| Stock Awards | $86,612 |
| Other | $11,056 |
| Total | $680,039 |
Wentworth received $265.9K in option awards, accounting for 39% of the total pay in 2011.
Wentworth also received $62.1K in non-equity incentive plan, $254.4K in salary, $86.6K in stock awards and $11.1K in other compensation.
Rankings
In 2011, Kerry A. Wentworth's compensation ranked 7,040th out of 10,747 executives tracked by ExecPay. In other words, Wentworth earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,040 out of 10,747 | 35th |
Division Manufacturing | 2,573 out of 3,960 | 35th |
Major group Chemicals And Allied Products | 621 out of 1,038 | 40th |
Industry group Drugs | 424 out of 786 | 46th |
Industry Biological Products, Except Diagnostic Substances | 70 out of 162 | 57th |
Source: SEC filing on March 10, 2014.
Wentworth's colleagues
We found four more compensation records of executives who worked with Kerry A. Wentworth at Agenus in 2011.